Anticoagulation is an essential component in haemodialysis, which seeks to maintain the delicate balance between preventing clot formation within the extracorporeal circuit and minimising bleeding ...

For permission requests, please contact NEJM Reprints at [email protected] From the Medical Research Department of the Yamins Research Laboratory, Beth Israel Hospital, and the Department of Medicine, ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced in the United States two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex ® IV bags.

TCT 136: We Tested a Novel CT-Guided Algorithm for TAVI Sizing and Placement in Patients With Severe Bicuspid Aortic Stenosis Incorporating Both Downsizing and Supra-Annular Placement Using Sapien ...

After more than 70 years of effective clinical use, heparin remains the most common anticoagulant in use and one of the most commonly prescribed drugs to hospitalized patients. However, the biologic ...

New research reveals that patients receiving heparin therapy were diagnosed with Alzheimer's disease up to two years later, suggesting a possible protective effect of this common anticoagulant. Study: ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...